PCN65 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH STAGE III OR IV FOLLICULAR LYMPHOMA RECEIVING 90Y-IBRITUMOMABTIUXETAN FOLLOWING FIRST-LINE CHEMOTHERAPY
May 1, 2008, 00:00
10.1016/S1098-3015(10)70243-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)70243-6/fulltext
Title :
PCN65 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH STAGE III OR IV FOLLICULAR LYMPHOMA RECEIVING 90Y-IBRITUMOMABTIUXETAN FOLLOWING FIRST-LINE CHEMOTHERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70243-6&doi=10.1016/S1098-3015(10)70243-6
First page :
Section Title :
Open access? :
No
Section Order :
896